Assignee
SCHERING CORP
US·1,753 granted patents·304 pending applications·43,829 citations·filing 1970–2012
Top patents by PatentIndex Score
2,057 records- 0199US6495667B1Il-b30 antibodiesSCHERING CORP·Filed 2000·Granted Dec 17, 2002·166 cites·8 claims
- 0299US4929641AMercapto-acylamino acid antihypertensivesSCHERING CORP·Filed 1988·Granted May 29, 1990·164 cites·20 claims
- 0399US4659716AAntihistaminic 8-(halo)-substituted 6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridinesSCHERING CORP·Filed 1986·Granted Apr 21, 1987·145 cites·16 claims
- 0498US7025962B1Mammalian cell surface antigens; related reagentsSCHERING CORP·Filed 2000·Granted Apr 11, 2006·346 cites·8 claims
- 0598US6838475B2Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jan 4, 2005·121 cites·43 claims
- 0698US6821978B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2001·Granted Nov 23, 2004·140 cites·34 claims
- 0798US6756481B2IL-23 receptor binding compositionsSCHERING CORP·Filed 2001·Granted Jun 29, 2004·103 cites·5 claims
- 0898US6329395B1Neuropeptide Y5 receptor antagonistsSCHERING CORP·Filed 1999·Granted Dec 11, 2001·186 cites·9 claims
- 0998US5883096AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 16, 1999·164 cites·17 claims
- 1098US5874442ATricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseaseSCHERING CORP·Filed 1996·Granted Feb 23, 1999·129 cites·7 claims
- 1198US4587258AAngiotensin-converting enzyme inhibitorsSCHERING CORP·Filed 1984·Granted May 6, 1986·197 cites·30 claims
- 1298US4582402AColor-imparting contact lensesSCHERING CORP·Filed 1984·Granted Apr 15, 1986·175 cites·6 claims
- 1398US4450164AImidazo[1,2-A]pyridines and useSCHERING CORP·Filed 1982·Granted May 22, 1984·207 cites·42 claims
- 1497US7417045B2Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Aug 26, 2008·64 cites·50 claims
- 1597US6689765B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2002·Granted Feb 10, 2004·71 cites·12 claims
- 1697US6479634B1IL-B30 proteinsSCHERING CORP·Filed 2000·Granted Nov 12, 2002·55 cites·8 claims
- 1797USRE37721EHydroxy-substituted azetidinone compounds useful as hypocholesterolemic agentsSCHERING CORP·Filed 2000·Granted May 28, 2002·99 cites·13 claims
- 1897US6391865B1Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2000·Granted May 21, 2002·94 cites·19 claims
- 1997US6326380B1Thrombin receptor antagonistsSCHERING CORP·Filed 2000·Granted Dec 4, 2001·103 cites·10 claims
- 2097US6294554B1Muscarinic antagonistsSCHERING CORP·Filed 2000·Granted Sep 25, 2001·70 cites·17 claims
- 2197US6207822B1Process for the synthesis of azetidinonesSCHERING CORP·Filed 1999·Granted Mar 27, 2001·163 cites·17 claims
- 2297US6111090AMammalian cell surface antigens; related reagentsSCHERING CORP·Filed 1997·Granted Aug 29, 2000·351 cites·36 claims
- 2397US6066636AMuscarinic antagonistsSCHERING CORP·Filed 1999·Granted May 23, 2000·96 cites·10 claims
- 2497US6063847AThrombin receptor antagonistsSCHERING CORP·Filed 1998·Granted May 16, 2000·180 cites·18 claims
- 2597US5952349AMuscarinic antagonists for treating memory lossSCHERING CORP·Filed 1997·Granted Sep 14, 1999·165 cites·14 claims
- 2697US5846966ACombinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase InhibitorsSCHERING CORP·Filed 1997·Granted Dec 8, 1998·171 cites·10 claims
- 2797US5687710AInhaler for powdered medications having spiral deagglomeration chamberSCHERING CORP·Filed 1995·Granted Nov 18, 1997·223 cites·12 claims
- 2897US5661152ATricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Aug 26, 1997·137 cites·23 claims
- 2997US5656624A4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agentsSCHERING CORP·Filed 1994·Granted Aug 12, 1997·115 cites·3 claims
- 3097US5272167APharmaceutically active compoundsSCHERING CORP·Filed 1990·Granted Dec 21, 1993·104 cites·6 claims
- 3197US5091431APhosphodiesterase inhibitorsSCHERING CORP·Filed 1989·Granted Feb 25, 1992·73 cites·6 claims
- 3297US5089496ABenzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergiesSCHERING CORP·Filed 1989·Granted Feb 18, 1992·138 cites·49 claims
- 3397US4668240APigment colored contact lenses and method for making sameSCHERING CORP·Filed 1985·Granted May 26, 1987·151 cites·21 claims
- 3497US4358453A1,2,4-Triazolo[4,3-a]pyridinesSCHERING CORP·Filed 1982·Granted Nov 9, 1982·59 cites·20 claims
- 3597US4352808A3-Aralkyloxy-2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes and related derivatives, their use as antimicrobials and pharmaceutical formulations useful thereforeSCHERING CORP·Filed 1980·Granted Oct 5, 1982·111 cites·24 claims
- 3697US4311857A1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their manufacture and intermediates useful therein, methods for their use as antibacterial agents and compositions useful thereforSCHERING CORP·Filed 1980·Granted Jan 19, 1982·67 cites·7 claims
- 3797US4235892A1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful thereforSCHERING CORP·Filed 1979·Granted Nov 25, 1980·94 cites·21 claims
- 3897US4156683AComplexes of macrocyclic compoundsSCHERING CORP·Filed 1975·Granted May 29, 1979·62 cites·42 claims
- 3996US7807160B2Engineered anti-IL-23 antibodiesSCHERING CORP·Filed 2006·Granted Oct 5, 2010·65 cites·4 claims
- 4096US7566718B2Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activitySCHERING CORP·Filed 2006·Granted Jul 28, 2009·73 cites·41 claims
- 4196US7217796B2Neutralizing human anti-IGFR antibodySCHERING CORP·Filed 2003·Granted May 15, 2007·105 cites·81 claims
- 4296US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 4396US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 4496US6835825B1Method for detecting IL-B30 polynucleotidesSCHERING CORP·Filed 2000·Granted Dec 28, 2004·53 cites·13 claims
- 4596US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 4696US6645987B2Nor-seco himbacine derivatives useful as thrombin receptor antagonistsSCHERING CORP·Filed 2001·Granted Nov 11, 2003·97 cites·14 claims
- 4796US6562578B1IL-17-like cytokine binding compounds and antibodiesSCHERING CORP·Filed 2000·Granted May 13, 2003·63 cites·8 claims
- 4896US6440974B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2001·Granted Aug 27, 2002·53 cites·9 claims
- 4996US6410541B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2001·Granted Jun 25, 2002·56 cites·9 claims
- 5096US6399615B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2000·Granted Jun 4, 2002·55 cites·15 claims
Showing the top 50 of 2,057 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SCHERING CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →